Tibet Rhodiola Pharmaceutical Holding

Tibet Rhodiola Pharmaceutical Holding EBIT per Employee

The EBIT per Employee of Tibet Rhodiola Pharmaceutical Holding (600211.SS) as of Oct 19, 2026 is 1.50 M CNY. In the previous year, EBIT per Employee was 1.89 M CNY — a change of -20.32% (lower).

EBIT per Employee

1.50 MCNY

YoY

-20.32%

Last updated:

EBIT per Employee of Tibet Rhodiola Pharmaceutical Holding is 2025 1.50 M CNY. EBIT per Employee of Tibet Rhodiola Pharmaceutical Holding was 2024 1.89 M CNY. It decreases by -20.32% lower compared to the previous year.

The Tibet Rhodiola Pharmaceutical Holding EBIT per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Employee
Date
EBIT per Employee
Jan 1, 2018
396,836.42 CNY
Jan 1, 2019
571,096.42 CNY
Jan 1, 2020
767,670.62 CNY
Jan 1, 2021
417,560.86 CNY
Jan 1, 2022
755,533.30 CNY
Jan 1, 2023
1.46 M CNY
Jan 1, 2024
1.89 M CNY
Jan 1, 2025
1.50 M CNY
The Tibet Rhodiola Pharmaceutical Holding EBIT per Employee history
YEAREBIT per EmployeeYoY
1.50 MCNY-20.32%
1.89 MCNY+29.07%
1.46 MCNY+93.50%
755,533.30CNY+80.94%
417,560.86CNY-45.61%
767,670.62CNY+34.42%
571,096.42CNY+43.91%
396,836.42CNY+14.32%
347,119.89CNY+7.93%
321,601.46CNY+85.46%
173,410.10CNY+315.92%
41,693.41CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Tibet Rhodiola Pharmaceutical Holding Stock analysis

What does Tibet Rhodiola Pharmaceutical Holding do? Tibet Rhodiola Pharmaceutical Holding Co, listed on the Shanghai Stock Exchange under ticker 600211.SS, operates as a pharmaceutical company based in Lhasa, China. The company's ISIN is CNE000000ZW7. Founded through an IPO on July 21, 1999, it specializes in the manufacture and wholesale of pharmaceutical products. Its headquarters are located in Lhasa, Xizang, and it employs 615 full-time staff. The firm distributes proprietary drug products and processes pharmaceuticals, conducting business primarily across South China, North China, East China, Central China, and overseas markets. The company's website is http://www.xzyy.cn. It does not provide details on specific products, acquisitions, or financial figures beyond the IPO date and employee count. The company focuses on pharmaceutical manufacturing and distribution within its operational regions, with no additional information provided on its product lines or market share. Tibet Rhodiola Pharmaceutical Holding is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tibet Rhodiola Pharmaceutical Holding stock

EBIT per Employee of Tibet Rhodiola Pharmaceutical Holding is 1.50 M CNY in 2025.

EBIT per Employee of Tibet Rhodiola Pharmaceutical Holding changed from 1.89 M CNY to 1.50 M CNY, representing a -20.32% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee Tibet Rhodiola Pharmaceutical Holding since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's Tibet Rhodiola Pharmaceutical Holding historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — Tibet Rhodiola Pharmaceutical Holding

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Tibet Rhodiola Pharmaceutical Holding